InvestorsHub Logo
Followers 15
Posts 1316
Boards Moderated 0
Alias Born 07/27/2015

Re: None

Saturday, 11/12/2022 9:49:23 PM

Saturday, November 12, 2022 9:49:23 PM

Post# of 462435
Looks like Missling will no longer be the speaker for the conference late November.

Daniel Klamer

Implementing Genetic Analysis in Clinical Trials to Illuminate Genetic Biomarkers in Rett Syndrome
Time: 1:45 pm
Day: Day Two

Details:

Implementing and executing clinical trial protocol for genetic analysis
Exploring whole blood transcriptomics analysis
Analysis of clinical endpoints and biomarkers of response



https://neurodevelopmental-drug-development.com/speaker/chrisopher-u-missling/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News